ramucirumab,pembrolizumab
eli lilly,merck
['s1800a', 'lung', 'sclc', 'nsclc', 'ramucirumab', 'pembrolizumab']
#asco22 dr. presents the phase ii randomized portion of lung-map s1800a looking at pembrolizumab + ramucirumab vs chemotherapy in pts with nsclc and prior io. can vegf inhibition induce responses? 
Director of Thoracic Oncology & Developmental Therapeutics @LombardiCancer, Associate Professor @Georgetown University #LCSM #HereWeGo #ITYSL He/Him